
Best for Visible starting price and service-area statement
Wellorithm
6.2/10Wellorithm stands out here for visible starting price and service-area statement, based on dated commercial evidence—not medical outcomes or individual suitability.3
A source-bound comparison of price visibility, formulation wording, clinician-process evidence, payment language, and fulfillment gaps.
Affiliate disclosure: We may earn a commission if you sign up through links below — this doesn't affect our rankings.
This page exists because Synergy RX and CareBareRX were in the accepted 13-program pool without a dedicated comparison route. It does not repeat the broader seven-program page: the decision is whether enough public evidence exists to estimate the commercial commitment without filling gaps.
Synergy RX’s checked page left GLP-1 price, payment path, and timing unstated. CareBareRX published a starting price, HSA/FSA language, and shipping window while leaving the clinician-review timeline unstated. Wellorithm and Enhance.MD serve as disclosure benchmarks, not substitute winners. Compounded drugs are not FDA-approved, and every route remains inert.
Use this pair as a commercial-field audit. Request the first invoice, recurring cadence, minimum term, renewal date, cancellation cutoff, refund rule, itemized services, dispensing entity, pharmacist-access route, supplies, and destination surcharge. For Synergy RX, those fields are questions because the checked page did not publish them. For CareBareRX, the visible amount and shipping phrase still need an all-in written quote and a defined clock.


Quick answer · CareBareRX
CareBareRX published more of the pair’s commercial fields, but product-status wording and clinician-review gaps prevent a recommendation.2
3.9/10Choose by intent
Jump to the scored card, verify the cited terms, or use the private matching path. A commercial fit is not a treatment recommendation.

Best for Visible starting price and service-area statement
Wellorithm stands out here for visible starting price and service-area statement, based on dated commercial evidence—not medical outcomes or individual suitability.3
Best for Published first-month and recurring-price evidence with ongoing provider care
Enhance.MD stands out here for published first-month and recurring-price evidence with ongoing provider care, based on dated commercial evidence—not medical outcomes or individual suitability.4

Best for Published starting-price and shipping evidence with explicit clinician-workflow gaps
CareBareRX stands out here for published starting-price and shipping evidence with explicit clinician-workflow gaps, based on dated commercial evidence—not medical outcomes or individual suitability.2
At-a-glance comparison
Sort by the weighted score or published starting price. Every score remains tied to the five criteria below.
| Logo | Provider | Starting price | Medications offered | Insurance | Average wait | Clinic Scout score | Public review signal | Offer / promo | Next steps |
|---|---|---|---|---|---|---|---|---|---|
![]() | Wellorithmaffiliate relationship · commission may apply | Advertised from $147; later-month and dose-dependent totals require confirmation3 | Compounded options; the checked page says FDA has not reviewed them for safety, quality, or effectiveness3 | No insurance required; HSA/FSA described; reimbursement is not guaranteed3 | Free direct-to-door shipping stated; dispatch and delivery timing not stated3 | 6.2/10 | Current offerNo verified promo codeChecked 2026-07-23 | ||
| Enhance.MDaffiliate relationship · commission may apply | First month advertised from $112; the checked page also states $212/month4 | Compounded medication; not FDA-approved; online consultation required4 | HSA/FSA described; insurance coverage not stated4 | Medication shipped to the door; the checked page states a 12-week cadence but no delivery window4 | 5.7/10 | Current offerNo verified promo codeChecked 2026-07-23 | |||
![]() | CareBareRXaffiliate relationship · commission may apply | Advertised from $199; total and ongoing cost require confirmation2 | Compounded semaglutide and tirzepatide referenced; compounded drugs are not FDA-approved, and the seller's brand-parenthetical wording is not repeated here2 | No insurance required; HSA/FSA payments described; reimbursement is not guaranteed2 | Free shipping stated as 1–2 days; clinician-review timing not stated2 | 3.9/10 | Current offerNo verified promo codeChecked 2026-07-23 | ||
![]() | Synergy RXaffiliate relationship · commission may apply | GLP-1 program price not stated on the checked page1 | Both FDA-approved brand-name and compounded GLP-1 formulations are referenced; exact selection requires licensed-provider review1 | Not stated for the checked GLP-1 offer1 | Discreet door shipping stated; timing not stated1 | 2.9/10 | Current offerNo verified promo codeChecked 2026-07-23 |
How we evaluated · why trust this
We compared 4 providers, checked 5 dated sources, and applied 5 published criteria. Scores use the same weighted rubric in the table and every provider card. Commission is excluded from scoring.
Lead generation, not advertising. Free · No commitment · 30 seconds. We do not share contact details unless the person separately requests matching and gives explicit consent.
Read the full scoring methodSource-backed deep cards
Pros, limitations, subscores, and bottom lines come from the same dated evidence that drives the table—not a second hidden ranking.

#1 · Best for Visible starting price and service-area statement
Bottom line
Wellorithm stands out here for visible starting price and service-area statement, based on dated commercial evidence—not medical outcomes or individual suitability.3
#2 · Best for Published first-month and recurring-price evidence with ongoing provider care
Bottom line
Enhance.MD stands out here for published first-month and recurring-price evidence with ongoing provider care, based on dated commercial evidence—not medical outcomes or individual suitability.4

#3 · Best for Published starting-price and shipping evidence with explicit clinician-workflow gaps
Bottom line
CareBareRX stands out here for published starting-price and shipping evidence with explicit clinician-workflow gaps, based on dated commercial evidence—not medical outcomes or individual suitability.2

#4 · Best for Readers willing to verify missing commercial fields directly
Bottom line
Synergy RX stands out here for readers willing to verify missing commercial fields directly, based on dated commercial evidence—not medical outcomes or individual suitability.1
Section winners
These are evidence-category leaders, not medical recommendations.

If you want Visible starting price and service-area statement
Wellorithm stands out here for visible starting price and service-area statement, based on dated commercial evidence—not medical outcomes or individual suitability.3
Read Wellorithm reviewIf you want Published first-month and recurring-price evidence with ongoing provider care
Enhance.MD stands out here for published first-month and recurring-price evidence with ongoing provider care, based on dated commercial evidence—not medical outcomes or individual suitability.4
Read Enhance.MD review
If you want Published starting-price and shipping evidence with explicit clinician-workflow gaps
CareBareRX stands out here for published starting-price and shipping evidence with explicit clinician-workflow gaps, based on dated commercial evidence—not medical outcomes or individual suitability.2
Read CareBareRX reviewSource ledger
Reviewed against cited first-party and primary sources · Sources checked 2026-07-23 · How evidence review works